Efficacy and safety of camrelizumab combined with apatinib in the treatment of advanced gastric cancer: Preliminary results from a multicenter, prospective study.

被引：0
|
作者：
He, Yifu
Hu, Bing
Liu, Ke
Cheng, Xiaofei
Cheng, Huaidong
Chen, Mo
Hu, Changlu
Li, Chenghui
Mei, Xinkuan
Liu, Jianfeng
Liu, Hu
Wang, Gang
Li, Hongxia
Zhang, Dingqing
Luo, Huiqin
机构：
[1] Univ Sci & Technol China, Affiliated Hosp 1, Hefei, Peoples R China
[2] Anhui Med Univ, Chaohu Hosp, Hefei, Peoples R China
[3] Peoples Liberat Army Navy Anqing Hosp, Anqing, Peoples R China
[4] Anhui Med Univ, Hosp 2, Hefei, Peoples R China
[5] Anhui 2 Prov Peoples Hosp, Hefei, Peoples R China
[6] Anhui Prov Canc Hosp, Hefei, Peoples R China
[7] Anqing Municipal Hosp, Anqing, Peoples R China
[8] Fuyang Canc Hosp, Fuyang, Peoples R China
[9] Lujiang Cty Hosp Tradit Chinese Med, Hefei, Peoples R China
[10] Hefei First Peoples Hosp, Hefei, Peoples R China
[11] Qianshan Hosp Tradit Chinese Med, Anqing, Peoples R China
[12] USTC West Dist, Affiliated Hosp 1, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16035
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A prospective, multicenter, real-world study of apatinib in the treatment of gastric cancer
    Xiong, J.
    Yang, J.
    Li, W.
    Xiong, H.
    Liu, G.
    Wu, F.
    Fan, N.
    Zeng, X.
    Huang, F.
    Yang, L.
    Tu, X.
    Shi, C.
    Yi, B.
    Ye, J.
    Li, P.
    Tang, C.
    Huang, J.
    Hou, P.
    Zang, W.
    Tan, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1060 - S1061
  • [22] Original Efficacy and safety of Camrelizumab combined with Abraxane plus lobaplatin regimen for advanced gastric cancer
    Ma, Jia
    Zhang, Weizheng
    Du, Jia
    Li, Jiang
    Lin, Guangshuai
    Tian, Youfu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (02): : 1485 - 1493
  • [23] Apatinib combined with SOX neoadjuvant therapy for locally advanced gastric cancer: A multicenter, single-armed, prospective study
    Lin, Jian-Xian
    Huang, Changming
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [24] Camrelizumab plus apatinib for patients with advanced mucosal melanoma: A prospective single-arm study.
    Zou, Zhengyun
    Zhao, Lianjun
    Ren, Yu
    Sha, Huizi
    Liu, Baorui
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Camrelizumab combined with apatinib in the treatment of patients with advanced gastric cancer and colorectal cancer: One-arm exploratory clinical trial
    Xiao, L.
    Zhang, Y.
    Lin, Q.
    ANNALS OF ONCOLOGY, 2020, 31 : S429 - S429
  • [26] Efficacy and safety of apatinib in the treatment of advanced platinum-resistant recurrent epithelial ovarian cancer: A retrospective study.
    Pan, Zhongmian
    Luo, Zhongbin
    He, Hongying
    Chen, Yujie
    Zhao, Bingbing
    Yang, Zhijun
    Li, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17594 - E17594
  • [27] Efficacy and safety of second-line camrelizumab combined with apatinib and chemotherapy in patients with advanced lung adenocarcinoma: A prospective, open-label, multicentric study
    Yao, Yiwei
    Wang, Yong
    Du, Yingying
    Jiang, Fengshou
    Liang, Hui
    Bi, Minghong
    Xie, Hua
    Peng, Wanren
    Pan, Yueyin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [28] Efficacy and safety of camrelizumab combined with chemotherapy versus chemotherapy alone as preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma: Preliminary results from a multicenter, prospective, randomized controlled study
    Zhang, Renquan
    Song, De Sheng
    Liu, Wei
    Yao, Long
    Chen, An Guo
    Ge, Wei
    Hu, Shao Hui
    Chen, Jian
    Huang, Yun Long
    Xun, Jun Rui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Prospective, multicenter, noninterventional and registry clinical study of apatinib in patients with advanced gastric cancer.
    Bai, Chunmei
    Zhong, Diansheng
    Zhang, Ruixing
    Ren, Xiubao
    Liu, Likun
    Du, Nan
    Yu, Junyan
    Yang, Mudan
    Zang, Aimin
    Diao, Jianfeng
    Ren, Yuchuan
    Fu, Zhanzhao
    MA, Liwen
    Zhang, Lei
    Gao, Jinghua
    Li, Guozhong
    Guo, Jun
    Zhang, Junping
    Jia, Junmei
    Zhang, Wenzheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [30] Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial
    Lin, Jian-Xian
    Tang, Yi-Hui
    Zheng, Hua-Long
    Ye, Kai
    Cai, Jian-Chun
    Cai, Li-Sheng
    Lin, Wei
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lu, Jun
    Chen, Qi-Yue
    Cao, Long-Long
    Zheng, Chao-Hui
    Li, Ping
    Huang, Chang-Ming
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345